Merck halts testing of combination drug for lung cancer treatment 

Merck said on Thursday it was halting a trial of a combination immunotherapy in patients with a type of lung cancer after an interim analysis showed the drug was unlikely to succeed.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM